Wordt geladen...
Personalizing medicine for metastatic colorectal cancer: Current developments
Metastatic colorectal cancer (mCRC) is still one of the tumor types with the highest incidence and mortality. In 2012, colorectal cancer was the second most prevalence cancer among males (9%) and the third among females (8%). In this disease, early diagnosis is important to improve treatment outcome...
Bewaard in:
| Hoofdauteurs: | , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Baishideng Publishing Group Inc
2014
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4130849/ https://ncbi.nlm.nih.gov/pubmed/25132758 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v20.i30.10425 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|